​

Mesoblast (MESO) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

MESO Stock Forecast

Mesoblast (MESO) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $11.50, with a high of $12.00 and a low of $11.00. This represents a 11.54% increase from the last price of $10.31.

- $4 $8 $12 $16 $20 High: $12 Avg: $11.5 Low: $11 Last Closed Price: $10.31

MESO Stock Rating

Mesoblast stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (44.44%), 4 Hold (44.44%), 1 Sell (11.11%), and 0 Strong Sell (0.00%).

Buy
Total 9 0 1 4 4 Strong Sell Sell Hold Buy Strong Buy

MESO Price Target Upside V Benchmarks

TypeNameUpside
StockMesoblast11.54%
SectorHealthcare Stocks 35.25%
IndustryBiotech Stocks 86.56%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$11.50
Last Closing Price$10.31$10.31$10.31
Upside/Downside--11.54%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2521---3
Mar, 2521---3
Feb, 2521---3
Jan, 2521---3
Dec, 2421---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 24, 2024Jason McCarthyMaxim Group$12.00$6.7478.04%16.39%
Jul 23, 2024Edward TenthoffPiper Sandler$11.00$8.2733.01%6.69%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 19, 2024Piper SandlerOverweightOverweighthold
Jul 23, 2024Piper SandlerOverweightupgrade
Aug 31, 2023CitigroupOverweightOverweighthold
Aug 31, 2023Canaccord GenuityBuyupgrade
Aug 04, 2023William BlairOutperformMarket Performdowngrade
Mar 09, 2023William BlairOutperforminitialise
Dec 06, 2022JefferiesHolddowngrade

Financial Forecast

EPS Forecast

$-10 $-5 $0 $5 $10 $15 Jun 20 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 20Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$-0.74$-0.82$-0.70-------
Avg Forecast$-1.17$-1.32$-1.06$-1.08$-0.52$-0.53$-0.31$0.39$0.33$2.33
High Forecast$-0.79$-0.89$-0.71$0.15$-0.50$-0.52$-0.13$1.95$1.62$11.59
Low Forecast$-1.45$-1.64$-1.32$-5.35$-0.56$-0.57$-0.49$-0.05$-0.05$-0.32
Surprise %-36.75%-37.88%-33.96%-------

Revenue Forecast

$0 $2B $3B $5B $6B $8B Jun 20 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 20Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$32.16M$7.46M$10.21M$7.50M------
Avg Forecast$44.18M$27.23M$13.89M$8.41M$7.49M$57.17M$376.13M$779.83M$1.77B$735.35M
High Forecast$52.53M$32.38M$16.52M$34.11M$8.04M$71.89M$513.34M$3.16B$7.20B$2.98B
Low Forecast$33.05M$20.37M$10.39M$1.04M$6.93M$42.37M$238.92M$96.59M$219.85M$91.08M
Surprise %-27.21%-72.62%-26.51%-10.80%------

Net Income Forecast

$-10B $-5B $0 $5B $10B $15B Jun 20 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 20Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$-77.94M$-98.81M$-91.35M$-81.89M------
Avg Forecast$-994.20M$-1.12B$-904.20M$-1.06B$-516.05M$-524.93M$-305.88M$387.28M$320.68M$2.30B
High Forecast$-668.54M$-755.49M$-608.01M$147.55M$-494.24M$-510.34M$-130.16M$1.93B$1.59B$11.43B
Low Forecast$-1.24B$-1.40B$-1.13B$-5.28B$-552.39M$-561.37M$-481.60M$-53.82M$-44.57M$-319.52M
Surprise %-92.16%-91.21%-89.90%-92.29%------

MESO Forecast FAQ

Is Mesoblast stock a buy?

Mesoblast stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 4 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Mesoblast is a favorable investment for most analysts.

What is Mesoblast's price target?

Mesoblast's price target, set by 9 Wall Street analysts, averages $11.5 over the next 12 months. The price target range spans from $11 at the low end to $12 at the high end, suggesting a potential 11.54% change from the previous closing price of $10.31.

How does Mesoblast stock forecast compare to its benchmarks?

Mesoblast's stock forecast shows a 11.54% upside, underperforming the average forecast for the healthcare stocks sector (35.25%) and underperforming the biotech stocks industry (86.56%).

What is the breakdown of analyst ratings for Mesoblast over the past three months?

  • April 2025: 66.67% Strong Buy, 33.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 66.67% Strong Buy, 33.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 66.67% Strong Buy, 33.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Mesoblast’s EPS forecast?

Mesoblast's average annual EPS forecast for its fiscal year ending in June 2024 is $-0.52, marking a 0% decrease from the reported $0 in 2023. Estimates for the following years are $-0.53 in 2025, $-0.31 in 2026, $0.39 in 2027, $0.33 in 2028, and $2.33 in 2029.

What is Mesoblast’s revenue forecast?

Mesoblast's average annual revenue forecast for its fiscal year ending in June 2024 is $7.49M, reflecting a -0.13% decrease from the reported $7.5M in 2023. The forecast for 2025 is $57.17M, followed by $376.13M for 2026, $779.83M for 2027, $1.77B for 2028, and $735.35M for 2029.

What is Mesoblast’s net income forecast?

Mesoblast's net income forecast for the fiscal year ending in June 2024 stands at $-516M, representing an 530.18% increase from the reported $-81.889M in 2023. Projections indicate $-525M in 2025, $-306M in 2026, $387.28M in 2027, $320.68M in 2028, and $2.3B in 2029.